Format

Send to

Choose Destination
Anticancer Res. 2009 Jul;29(7):2703-5.

Clinical characteristics of laryngeal cancer in BRCA-1 mutation carriers.

Author information

1
Department of Otolaryngology and Laryngological Oncology, Pomeranian Medical University, 71-252 Szczecin, Poland. jaworowska@tlen.pl

Abstract

BACKGROUND:

The aim of this study was to analyze the occurrence of clinical features characteristic of breast cancer type 1 susceptibility protein (BRCA-1)-dependent tumors in a series of BRCA-1 mutation carriers with laryngeal cancer.

PATIENTS AND METHODS:

The clinical features of five laryngeal cancer patients with BRCA-1 mutations registered in our center were analyzed for: sex, age at diagnosis, age at operation, tumor size and localization, histopathological subtype and grading, lymph node and distant metastases, mode of treatment and long term results of the therapy.

RESULTS:

The five patients were all men, with an average age at diagnosis of 52.4 years. The majority of the patients had clinical features typical of BRCA-1-dependent tumors: four out of the five patients had advanced staging at the time of diagnosis and in three of them the disorder disseminated within one year of follow-up.

CONCLUSION:

Since laryngeal carcinomas in men with BRCA-1 mutations show clinical features characteristic of BRCA-1 dependent tumors, it is reasonable to consider treatment modifications appropriate for this sub-group of tumors.

PMID:
19596949
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center